Texas seeks to block Kenvue dividend amid Tylenol lawsuit
Reuters· 2025-11-06 13:06
Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing ... ...
Duos Edge AI Joins Nomad Futurist Foundation as Inspiration Sponsor
Globenewswire· 2025-11-06 13:06
Partnership advances digital infrastructure education and empowers next generation of technology leadersJACKSONVILLE, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, modular, and scalable Edge Data Center (“EDC”) solutions, today announced its partnership with the Nomad Futurist Foundation as an Inspiration Sponsor. This collaboration underscores a sha ...
Google may be Nvidia's biggest rival in chips — and now it's upping its game
MarketWatch· 2025-11-06 13:06
The company's seventh-generation TPU chip is custom-built to handle tasks such as large-scale AI model training and high-volume AI inference. ...
KDDI Corporation (KDDIY) Q2 2026 Earnings Call Prepared Remarks Transcript
Seeking Alpha· 2025-11-06 13:06
PresentationUnknown Executive Now we are going to start KDDI's earnings release conference for the second quarter of fiscal year ending March 2026. I'll be serving as the moderator. I am [ Hiraoka ] from Public Relations Department. Today, this earnings release in addition to the venue will be distributed on multiple channels, including YouTube. And the 3 types of documents related to earnings release are uploaded on the website of KDDI. And those who are in the venue, please refer to the handout. Let me i ...
HelloFresh says it strongly disagrees with Grizzly Research take on business prospects
Reuters· 2025-11-06 13:06
HelloFresh said on Thursday it strongly disagreed with the interpretation by a Grizzly Research report on its current status of governance and business prospects, after the short seller said it had ta... ...
Is Bitmine Immersion Technologies (BMNR) Stock at $100 a Pipe Dream?
247Wallst· 2025-11-06 13:05
If you're a cryptocurrency believer but don't want to bother with cold wallets and crypto exchanges, there's an indirect way to invest in Ethereum (CRYPTO:ETH). ...
Here’s What Pressuring UniFirst Corporation (UNF)
Yahoo Finance· 2025-11-06 13:05
Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Small-Cap Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, the fund returned 7.18% compared to 8.97% for the MSCI USA Small-Cap Value Index (the “Index”) and 12.60% return for the Russell 2000 Value Index. Positive contributions from a wide range of businesses led the fund’s performance in the quarter. For more information on the fund’s ...
Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update
Accessnewswire· 2025-11-06 13:05
89% of evaluable mipletamig patients achieve remission in combination therapy for frontline AML across two trials Introduces first trispecific molecules, APVO451 and APVO452, advancing therapies designed to overcome immune suppression in certain solid tumors Both molecules leverage Aptevo's unique use of the CRIS-7-derived CD3 binding domain, associated with favorable safety outcomes in the clinic; CD3 T-cell engager portfolio expanded to five Company raises $18.7 million in the third quarter, $4.1 million ...
New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response
Businesswire· 2025-11-06 13:05
PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new data demonstrating that its Guardant Reveal® blood test helps clinicians to assess the effectiveness of chemotherapy in patients with advanced solid tumors months earlier than conventional methods. This is the first robust clinical validation study of pan-cancer chemotherapy monitoring, published in the Journal of Liquid Biopsy. The study used a tissue-free, methylat. ...
Fiserv Q3: Flat Revenue, Falling Earnings, And A Recovery Pushed Beyond 2026
Seeking Alpha· 2025-11-06 13:05
When a stock wipes out nearly half of its market cap in a single day, there are usually structural issues behind it, and we won't likelyI'm specialized in fundamental equity research, global macro strategy, and top-down portfolio construction. I'm a senior analyst at a multi-strategy hedge fund with 7 years of experience. I graduated from UCLA with a degree of Business Economics and UMich Ross School of Business with a Master of Accounting. My articles primarily focus on company fundamentals.Analyst’s Discl ...